Systems medicine modeling for multiple sclerosis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Opinion in Systems Biology

• Publication date

  2017-06-01

• Fields of study

  Medicine, Mathematics, Engineering

• Identifiers
  DOI 10.1016/J.COISB.2017.05.002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis

  2017cited by this paper
• Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice

  2017cited by this paper
• Demyelination patterns in a mathematical model of multiple sclerosis

  2016cited by this paper
• Neuroprotective therapies for multiple sclerosis and other demyelinating diseases

  2016cited by this paper
• Computational modeling of brain pathologies: the case of multiple sclerosis

  2016cited by this paper
• Multiple sclerosis—a quiet revolution

  2015cited by this paper
• Signaling networks in MS: A systems-based approach to developing new pharmacological therapies

  2015cited by this paper
• Neurodegeneration in multiple sclerosis is a process separate from inflammation: Yes

  2015cited by this paper
• Neurodegeneration in multiple sclerosis is a process separate from inflammation: No

  2015cited by this paper
• Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque

  2015cited by this paper
• A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis

  2015cited by this paper
• Trans‐synaptic axonal degeneration in the visual pathway in multiple sclerosis

  2014cited by this paper
• The central role of mitochondria in axonal degeneration in multiple sclerosis

  2014cited by this paper
• Modules, networks and systems medicine for understanding disease and aiding diagnosis

  2014cited by this paper
• Defining the clinical course of multiple sclerosis

  2014cited by this paper
• Autoimmunity and tumor immunology: two facets of a probabilistic immune system

  2014cited by this paper
• Prognostic indicators for long-term disability in multiple sclerosis patients.

  2013cited by this paper
• Predicting Relapsing-Remitting Dynamics in Multiple Sclerosis Using Discrete Distribution Models: A Population Approach

  2013cited by this paper
• Natalizumab: bench to bedside and beyond.

  2013cited by this paper
• Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls.

  2013cited by this paper
• Treatment Optimization in MS: Canadian MS Working Group Updated Recommendations

  2013cited by this paper
• Transient oscillatory dynamics of interferon beta signaling in macrophages

  2013cited by this paper
• Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis

  2013cited by this paper
• Pathology and disease mechanisms in different stages of multiple sclerosis.

  2013cited by this paper
• Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity

  2013cited by this paper
• A Mechanistic, Stochastic Model Helps Understand Multiple Sclerosis Course and Pathogenesis

  2013cited by this paper
• Predictors of long‐term outcome in multiple sclerosis patients treated with interferon beta

  2013cited by this paper
• Progressive multiple sclerosis: pathology and pathogenesis

  2012cited by this paper
• Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

  2011cited by this paper
• Modeling the effector - regulatory T cell cross-regulation reveals the intrinsic character of relapses in Multiple Sclerosis

  2011cited by this paper
• A simple work flow for biologically inspired model reduction - application to early JAK-STAT signaling

  2011cited by this paper
• A mathematical model of cell death in multiple sclerosis.

  2011cited by this paper
• Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis

  2010cited by this paper
• Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.

  2010cited by this paper
• The Causal Cascade to Multiple Sclerosis: A Model for MS Pathogenesis

  2009cited by this paper
• Systems biology and its application to the understanding of neurological diseases

  2009cited by this paper
• Model-based analysis of interferon-beta induced signaling pathway

  2008cited by this paper
• Understanding NF-κB signaling via mathematical modeling

  2008cited by this paper
• A COMPUTATIONAL MODEL FOR LESION DYNAMICS IN MULTIPLE SCLEROSIS OF THE BRAIN

  2008cited by this paper
• A Network Analysis of the Human T-Cell Activation Gene Network Identifies Jagged1 as a Therapeutic Target for Autoimmune Diseases

  2007cited by this paper
• Therapeutic potential of oxidative stress reduction in Alzheimer's disease

  2006cited by this paper
• Natural history of multiple sclerosis: a unifying concept.

  2006cited by this paper
• Robustness of the signal transduction system of the mammalian JAK/STAT pathway and dimerization steps.

  2006cited by this paper
• Remyelination is extensive in a subset of multiple sclerosis patients.

  2006cited by this paper
• Neuroinformatics in clinical practice: are computers going to help neurological patients and their physicians?

  2006cited by this paper
• Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression

  2004cited by this paper
• Control mechanism of JAK/STAT signal transduction pathway

  2003cited by this paper
• Blood-brain barrier disruption in multiple sclerosis

  2003cited by this paper
• Multiple sclerosis: a two-stage disease

  2001cited by this paper
• Dynamic Shuttling of Nuclear Factor κB between the Nucleus and Cytoplasm as a Consequence of Inhibitor Dissociation*

  2000cited by this paper
• BMC Systems Biology

  year unknowncited by this paper
• The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation

  year unknowncited by this paper

• The dynamics of relapses during treatment switch in relapsing-remitting multiple sclerosis.

  2022cites this paper
• Eckhaus and zigzag instability in a chemotaxis model of multiple sclerosis

  2018cites this paper